Katherine Turner
Direktor/Vorstandsmitglied bei Weeneebayko Area Health Authority
Profil
Katherine Turner is currently the Director of Clinical Operations at Cognate BioServices, Inc. and also holds a Director position at Weeneebayko Area Health Authority.
Previously, she worked as a Principal at Osiris Therapeutics, Inc. from 2000 to 2002.
Turner received her undergraduate degree from Saginaw Valley State University in 1985.
Aktive Positionen von Katherine Turner
| Unternehmen | Position | Beginn |
|---|---|---|
Cognate BioServices, Inc.
 Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | Corporate Officer/Principal | - |
| Weeneebayko Area Health Authority | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Katherine Turner
| Unternehmen | Position | Ende |
|---|---|---|
| OSIRIS THERAPEUTICS, INC. | Corporate Officer/Principal | 02.01.2002 |
Ausbildung von Katherine Turner
| Saginaw Valley State University (Michigan) | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Osiris Therapeutics, Inc.
 Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD. | Health Technology |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | Health Technology |
| Weeneebayko Area Health Authority |
